{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:27:09Z","timestamp":1783970829320,"version":"3.55.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,4]]},"DOI":"10.1212\/wnl.46.4.985","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:19:17Z","timestamp":1336915157000},"page":"985-991","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":191,"title":["A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors"],"prefix":"10.1212","volume":"46","author":[{"given":"M. J.","family":"Glantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. F.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Friedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Furie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Akerley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"4","volume":"148","year":"1992","unstructured":"Posner JB. Management of brain metastases. Rev Neurol 1992;148:477-487.","journal-title":"Rev Neurol"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.44.1.7"},{"key":"e_1_3_1_4_2","first-page":"3","volume":"17","year":"1960","unstructured":"Simonescu MD. Metastatic tumors of the brain. A follow-up study of 195 patients with neurosurgical considerations. J Neurosurg 1960;17:361-373.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_5_2","unstructured":"Paillas JE Pellet W. Brain metastasis. In: Vinken PJ Bruyn GW eds. Handbook of clinical neurology. New York: Elsevier 1976."},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","unstructured":"Posner JB. Clinical manifestations of brain metastases. In: Gilbert HA Posner JB Weiss L eds. Brain metastasis. Boston: GK Hall 1980:189-207.","DOI":"10.1007\/978-94-009-8799-9_11"},{"key":"e_1_3_1_7_2","first-page":"3","volume":"48","year":"1981","unstructured":"Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 1981;48:384-394.","journal-title":"Cancer"},{"key":"e_1_3_1_8_2","first-page":"3","volume":"1","year":"1983","unstructured":"Byrne TN, Cascino TL, Posner JB. Brain metastases from melanoma. J Neurooncol 1983;1:313-317.","journal-title":"J Neurooncol"},{"key":"e_1_3_1_9_2","first-page":"4","volume":"6","year":"1988","unstructured":"Flint G. Seizures and epilepsy. Br J Neurosurg 1988;6:419-421.","journal-title":"Br J Neurosurg"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.1.1"},{"key":"e_1_3_1_11_2","first-page":"3","volume":"16","year":"1981","unstructured":"Mahaley MS Jr, Dudka L. The role of anticonvulsant medications in the management of patients with anaplastic gliomas. Surg Neurol 1981;16:399-401.","journal-title":"Surg Neurol"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1984.61.1.0001"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.1.1"},{"key":"e_1_3_1_14_2","unstructured":"Dubinsky S Newmark ME. Skin rashes after antiepileptic drug use [abstract]. Epilepsia 1991;32(suppl 3):17."},{"key":"e_1_3_1_15_2","first-page":"2","volume":"16","year":"1985","unstructured":"Boarini DJ, Beck DW, VanGilder JC. Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 1985;16:290-292.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_16_2","first-page":"A","volume":"10","year":"1991","unstructured":"Hung S, Hilsenbeck S, Feun L. Seizure prophylaxis with phenytoin in patients with brain metastases [abstract]. Proc Am Soc Clin Oncol 1991;10:A1151.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_3_1_17_2","first-page":"5","volume":"45","year":"1982","unstructured":"Turnbull DM, Rawlins MD, Weightman D, Chadwick DW. A comparison of phenytoin and valproate in previously untreated adult epileptic patients. J Neurol Neurosurg Psychiatry 1982;45:55-59.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_18_2","first-page":"6","volume":"48","year":"1985","unstructured":"Callaghan N, Kenny RA, O'Neill B, Crowley M, Goggin T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry 1985;48:639-644.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Chadwick DW. Valproate monotherapy in the management of generalized and partial seizures. Epilepsia 1987;28(suppl 2): S12-S17.","DOI":"10.1111\/j.1528-1157.1987.tb05766.x"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.1.3"},{"key":"e_1_3_1_21_2","first-page":"2","volume":"39","year":"1989","unstructured":"Driefuss FE, Langer DH, Moline KA, Maxwell JE. Valproic acid hepatic fatalities. II. US experience since 1984. Neurology 1989;39:201-207.","journal-title":"Neurology"},{"key":"e_1_3_1_22_2","first-page":"9","volume":"41","year":"1991","unstructured":"Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. Neurology 1991;41:961-964.","journal-title":"Neurology"},{"key":"e_1_3_1_23_2","unstructured":"Willmore LJ Brugger AM Shu V the Depakote Complex Partial Seizure Research Group. Depakote in the treatment of complex partial seizures. A multi-center study [abstract]. Neurology 1994;44(suppl 2):295."},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.Suppl.6"},{"key":"e_1_3_1_25_2","first-page":"1","volume":"214","year":"1967","unstructured":"Goddard GV. Development of epileptic seizures through brain stimulation at low intensity. Nature 1967;214:1020-1021.","journal-title":"Nature"},{"key":"e_1_3_1_26_2","first-page":"5","volume":"11","year":"1987","unstructured":"Schmutz M. Relevance of kindling and related processes to human epileptogenesis. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:505-525.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"e_1_3_1_27_2","first-page":"2","volume":"72","year":"1988","unstructured":"Schmutz M, Klebs K, Baltzer V. Inhibition or enhancement of kindling evolution by antiepileptics. J Neural Transm 1988;72:245-257.","journal-title":"J Neural Transm"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290103"},{"key":"e_1_3_1_29_2","first-page":"5","volume":"28","year":"1993","unstructured":"Booth BM, Blow FC. The kindling hypothesis: further evidence from a U.S. national study of alcoholic men. Alcohol 1993;28:593-598.","journal-title":"Alcohol"},{"key":"e_1_3_1_30_2","first-page":"4","volume":"53","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.","journal-title":"J Am Stat Assoc"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2517-6161.1972.tb00885.x","volume":"34","year":"1972","unstructured":"Cox DR. Regression models and life tables. J R Stat Assoc 1972;34:187-202.","journal-title":"J R Stat Assoc"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","unstructured":"Leppik IE. Compliance during treatment of epilepsy. Epilepsia 1988;29(suppl 2):S79-S84.","DOI":"10.1111\/j.1528-1157.1988.tb05801.x"},{"key":"e_1_3_1_33_2","first-page":"4","volume":"34","year":"1972","unstructured":"Haque N, Thrasher K, Werk E. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin. J Clin Endocrinol Metab 1972;34:44-50.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_34_2","first-page":"2","volume":"8","year":"1977","unstructured":"Wassner SJ, Malekzadem MH, Pennisi AJ, et al. Allograft survival in patients receiving anticonvulsant medications. Clin Nephrol 1977;8:293-297.","journal-title":"Clin Nephrol"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.1.1"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1984.1"},{"key":"e_1_3_1_37_2","first-page":"2","volume":"254","year":"1985","unstructured":"Wong DD, Longnecker RG, Liepman M, Baker S, La Vergne M. Phenytoin-dexamethasone: a potential drug interaction [letter]. JAMA 1985;254:2062-2063.","journal-title":"JAMA"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.1.1"},{"key":"e_1_3_1_39_2","first-page":"1","volume":"61","year":"1977","unstructured":"Warren RD, Bender AR. Drug interactions with antineoplastic agents. Cancer Treat Rep 1977;61:1231-1241.","journal-title":"Cancer Treat Rep"},{"key":"e_1_3_1_40_2","first-page":"3","volume":"36","year":"1976","unstructured":"Reich SD, Bachur NR. Alterations in adriamycin efficacy by phenobarbital. Cancer Res 1976;36:3803-3806.","journal-title":"Cancer Res"},{"key":"e_1_3_1_41_2","first-page":"2","volume":"27","year":"1990","unstructured":"Fitzsimmons WE, Ghalie R, Kaizer H. The effect of hepatic enzyme inducers on busulfan neurotoxicity. Cancer Chemother Pharmacol 1990;27:226-228.","journal-title":"Cancer Chemother Pharmacol"},{"key":"e_1_3_1_42_2","unstructured":"Hansten PD Horn JR. Drug Interactions and Updates. 6th ed. Philadelphia: Lea & Febiger 1993."},{"key":"e_1_3_1_43_2","first-page":"1","volume":"208","year":"1979","unstructured":"Levin VA, Stearns J, Byrd A, et al. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chlorethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU. J Pharmacol Exp Ther 1979;208:1-6.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_1_44_2","first-page":"3","volume":"52","year":"1980","unstructured":"Muller PJ, Tator CM, Bloom M. The effect of phenobarbital on the toxicity and tumoricidal activity of CCNU in a murine brain tumor model. J Neurosurg 1980;52:359-366.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_45_2","first-page":"1","volume":"13","year":"1979","unstructured":"Koranyi L, Gero L. Influence of diphenylhydantoin on the effect of streptozocin. BMJ 1979;13:127.","journal-title":"BMJ"},{"key":"e_1_3_1_46_2","first-page":"1","volume":"13","year":"1994","unstructured":"Fetell MR, Grossman SA, Balmaceda C, et al. Clinical and pharmacologic study of pre-irradiation taxol administered as a 96 hour infusion in adults with newly diagnosed glioblastoma multiforme (GBM) [abstract]. Proc Am Soc Clin Oncol 1994;13:179.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.1.3"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6078.1"},{"key":"e_1_3_1_49_2","first-page":"2","volume":"1","year":"1979","unstructured":"Finchum RW, Schottelius DD. Decreased phenytoin levels in antineoplastic therapy. Ther Drug Monit 1979;1:277-283.","journal-title":"Ther Drug Monit"},{"key":"e_1_3_1_50_2","first-page":"5","volume":"7","year":"1982","unstructured":"Perucca E. Pharmacokinetic interactions with antiepileptic drugs. Clin Pharmacokinet 1982;7:57-84.","journal-title":"Clin Pharmacokinet"},{"key":"e_1_3_1_51_2","first-page":"7","volume":"24","year":"1983","unstructured":"Bollini P, Riva R, Albani F, et al. Decreased phenytoin levels during antineoplastic therapy: a case report. Epilepsia 1983;24:74-78.","journal-title":"Epilepsia"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198403000-00002"},{"key":"e_1_3_1_53_2","first-page":"9","volume":"112","year":"1988","unstructured":"Jarosinski PF, Moslow JA, Alexander MS, et al. Altered phenytoin clearance during intensive treatment for acute lymphoblastic leukemia. J Pediatr 1988;112:996-999.","journal-title":"J Pediatr"},{"key":"e_1_3_1_54_2","first-page":"3","volume":"43","year":"1988","unstructured":"Neef C, Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther 1988;43:372-375.","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(89)80475-9"},{"key":"e_1_3_1_56_2","first-page":"2","volume":"89","year":"1990","unstructured":"Dofferhoff ASM, Berendsen HH. Decreased phenytoin level after carboplatin treatment. Am J Med 1990;89:247-248.","journal-title":"Am J Med"},{"key":"e_1_3_1_57_2","first-page":"2","volume":"12","year":"1992","unstructured":"Ghosh C, Lazarus HM, Hewlett JS, Creger RJ. Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors. J Neurooncol 1992;12:25-32.","journal-title":"J Neurooncol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.46.4.985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T14:17:24Z","timestamp":1713968244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.46.4.985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,4]]}},"alternative-id":["10.1212\/WNL.46.4.985"],"URL":"https:\/\/doi.org\/10.1212\/wnl.46.4.985","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,4]]}}}